On March 31 the Food and Drug Administration warned nine companies to stop making 14 prescription opioids that were unapproved. After hearing feedback from the hospice and palliative care community, the FDA has reversed part of that ban and promises to continue to allow one form of liquid morphine (20 mg/ml morphine sulfate solution) available.
Read coverage from the Associated Press, New Health America blog, and the American Academy of Hospice and Palliative Medicine.
